Formal Name : N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
CAS Number : 1185887-21-1
Molecular Formula : C20H28N4O2
Formula Weight : 356.5
Formulation : A crystalline solid
Purity : ≥98%
λmax : 210, 303 nm
Stability : 2 years
AB-CHMINACA for sale
AB-FUBINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold higher affinity relating to the main CB1 receptor (Ki = 0.9 nM) in contrast to JWH 018 .
AB-FUBINACA was initially synthesized by Pfizer, Inc. as an effective powerful CB1 receptor modulator for possible therapeutic usage, however not too long ago had been discovered together with AB-PINACA in prohibited herbal products.
AB-CHMINACA is structurally relevant to AB-FUBINACA which includes a cyclohexyl group replaced for the 4-fluorophenyl group. The physical and toxicological attributes associated with the substance haven’t been identified. The product was created for research and forensic purposes.
This fine research chemical in our laboratory. We can ensure you that when you order from us you will get a high purity research chemical for your research purspose.
Presumes no tolerance
Threshold < 1 mg Light 1 – 2 mg
Common 1 – 3 mg
Strong 4 – 5 mg
Heavy > 5 mg
Total 1 – 2 hours
Onset 0 – 20 minutes
Peak 30 – 60 minutes
Offset 10 – 20 minutes
Afterglow 15 – 30 minutes
- USA: In January 2014, AB-FUBINACA was designated as a Schedule I controlled substance in the United States.